Initial Insulin Glargine Dosing for Type 2 Diabetes on Metformin
For a 70-kg adult with type 2 diabetes already taking metformin 1 g twice daily, start insulin glargine (Lantus) at 10 units once daily OR 0.2 units/kg/day (14 units for this patient), administered at the same time each day. 1, 2
Recommended Starting Dose
The 2025 ADA Standards of Care explicitly recommend 10 units per day OR 0.1-0.2 units/kg per day for basal insulin initiation in type 2 diabetes 1. The FDA label for Lantus confirms 10 units or 0.2 units/kg once daily as the recommended starting dose for insulin-naive type 2 diabetes patients 2.
For your 70-kg patient, this translates to:
- Conservative approach: 10 units daily (fixed dose)
- Weight-based approach: 14 units daily (0.2 units/kg × 70 kg)
Both are acceptable starting points. The weight-based approach may achieve target faster but carries no additional hypoglycemia risk when combined with metformin 3.
Key Administration Details
- Timing: Administer once daily at the same time every day (bedtime or morning—patient's choice for consistency) 2
- Continue metformin: Keep the current metformin 1 g twice daily regimen 1, 4
- Injection site: Rotate within the same region (abdomen, thigh, or deltoid) 2
Titration Strategy
After initiating, follow this evidence-based algorithm 1:
- Set fasting plasma glucose (FPG) goal: Typically 80-130 mg/dL for most adults
- Titration schedule: Increase by 2 units every 3 days until FPG goal is reached without hypoglycemia
- For hypoglycemia: If it occurs without clear cause, reduce dose by 10-20%
- Monitor: Check fasting blood glucose daily during titration
Evidence Supporting This Approach
The combination of basal insulin glargine with metformin is particularly effective and safe 4, 5. A landmark 2005 study demonstrated that adding once-daily glargine to metformin (with sulfonylurea) achieved superior HbA1c reduction (-1.64%) with significantly fewer hypoglycemic episodes (4.07 vs 9.87 events/patient-year) compared to premixed insulin 4.
More recent evidence from 2020 showed that even a higher starting dose of 0.3 units/kg in overweight/obese patients was safe, with only 11% experiencing confirmed hypoglycemia and zero severe hypoglycemia events 3. This suggests the standard 0.2 units/kg dose carries minimal hypoglycemia risk when combined with metformin.
Common Pitfalls to Avoid
- Do NOT administer intravenously or via insulin pump—subcutaneous only 2
- Do NOT mix or dilute Lantus with any other insulin or solution 2
- Do NOT underdose initially: Starting too conservatively (e.g., 0.1 units/kg) delays glycemic control without meaningful safety benefit when metformin is continued 3
- Do NOT discontinue metformin: The combination provides better glycemic control with less hypoglycemia and weight gain than insulin alone 4, 5
Why This Combination Works
Adding basal insulin to metformin monotherapy early in treatment provides superior efficacy/safety benefits 5. Metformin reduces insulin requirements, limits weight gain, and decreases hypoglycemia risk—making it the ideal partner for basal insulin initiation 4, 5.